Director, Dartmouth Cancer Center
Roy Herbst, MD, PhD, was named the director of Dartmouth Cancer Center effective July 13, 2026. He will lead efforts to expand access and help strengthen cancer research, education, and collaboration across Dartmouth Cancer Center, Dartmouth College, and Dartmouth Health.
Dr. Herbst is internationally recognized as one of the foremost leaders in the development of targeted and immune-based therapies for the treatment of lung cancer. His work throughout the past three decades has significantly advanced the standard of care for patients with lung cancer, greatly enhancing survival and quality of life beyond what was previously thought to be possible.
Throughout Dr. Herbst’s storied career, he has remained steadfastly committed to delivering exceptional and compassionate patient care, producing top-notch translational research, and providing enlightening educational experiences to trainees that will prepare them for successful and meaningful careers as healthcare providers and clinical researchers. He promotes an atmosphere of collegiality and collaboration, building translational bridges between basic and clinical researchers, as well as between academic and industry partners.
Dr. Herbst inspires his peers, colleagues, and trainees to strive for excellence in the laboratory, clinic, classroom, and community, and his legacy will make an impact on patients for years to come.